期刊文献+

噻托澳铵治疗慢性阻塞性肺病合并呼吸衰竭疗效分析 被引量:2

下载PDF
导出
摘要 慢胜阻塞性肺疾病(COPD)是一种以气道不可逆阻塞为特征的慢性疾病,其发病率和病死率较高。该病患病人数多,社会经济负担重,而且易反复发作,已成为世界各国共同关注的一个公共卫生问题。噻托溴铵作为治疗COPD稳定期患者的一线药物,其相关疗效的报道已有较多。我院采用噻托溴铵治疗COPD急性加重期合并呼吸衰竭患者,疗效满意,现报道如下。
出处 《浙江医学》 CAS 2010年第4期585-586,共2页 Zhejiang Medical Journal
  • 相关文献

参考文献7

  • 1COPD诊治指南(2007年修订版)[J].继续医学教育,2007,21(2):31-42. 被引量:367
  • 2朱元钰 陈文彬.呼吸病学[M].北京:人民卫生出版社,2003.408.
  • 3Littner M R,llowite J S,Tashkin D P,et al.Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease[J].Am J Respir Crit Care Med,2000,161(4 Pt 1):1136-1142.
  • 4Disse B,Speck G A,Rominger K L,et al.Tiotropium (Spiriva):mechanistical considerations and clinical profile in obstructive lung disease[J].Life Sci,1999,64(6-7):457-464.
  • 5郑劲平,康健,蔡柏蔷,周新,曹兆龙,白春学,钟南山.吸入噻托溴铵干粉与异丙托溴铵定量气雾剂治疗慢性阻塞性肺疾病的疗效与安全性比较[J].中华结核和呼吸杂志,2006,29(6):363-367. 被引量:158
  • 6O'Donnell D E,Fluge T,Gerken F,et al.Effects of tiotropium on lung hyperfintfation,dyspnoea and exercise tolerance in COPD[J].Eur Respir J,2004,23(6):832-840.
  • 7Casaburi R,Malheder D A,Jones P W,et al.A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease[J].Eur Respir J,2002,19(2):217-224.

二级参考文献11

  • 1刘升明,王小平,王大礼,周玉民,吕嘉春,郑劲平,钟南山,冉丕鑫.广东部分地区慢性阻塞性肺疾病发病状况调查[J].中华医学杂志,2005,85(11):747-752. 被引量:151
  • 2Barnes PJ,Stockley RA.COPD:current therapeutic interventions and future approaches.Eur Respir J,2005,25:1084-1106.
  • 3Disse B,Reichl R,Speck G,et al.Ba 679 BR,a novel long-acting anticholinergic bronchodilator.Life Sci,1993,52:537-544.
  • 4Takahashi T,Belvisi MG,Patel H,et al.Effect of Ba 679 BR,a novel long-acting anticholinergic agent,on cholinergic neurotransmission in guinea pig and human airways.Am J Respir Crit Care Med,1994,150(6 Pt 1):1640-1645.
  • 52003 Update:Workshop Report,Global Strategy for Diagnosis,Management,and Prevention of COPD.National Heart,Lung,and Blood Institute and World Health Organization,Global initiative for chronic obstructive lung disease (GOLD).Available from:http://www.goldeopd.org/
  • 6Casaburi R,Mahler DA,Jones PW,et al.A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease.Eur Respir J,2002,19:217-224.
  • 7Littner MR,Ilowite JS,Tashkin DP,et al.Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease.Am J Respir Crit Care Med,2000,161 (4 Pt 1):1136-1142.
  • 8Casaburi R,Briggs DD Jr,Donohue JF,et al.The spirometric efficacy of once-daily dosing with tiotropium in stable COPD:a 13-week multicenter trial.The US Tiotropium Study Group.Chest,2000,118:1294-1302.
  • 9O'Donnell DE,Fluge T,Gerken F,et al.Effects of tiotropium on lung hyperinflation,dyspnoea and exercise tolerance in COPD.Eur Respir J,2004,23:832-840.
  • 10Maltais F,Hamilton A,Marciniuk D,et al.Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD.Chest,2005,128:1168-1178.

共引文献662

同被引文献6

引证文献2

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部